Novan, Inc.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2008-01-01
- Employees
- 89
- Market Cap
- -
- Website
- http://www.novan.com
P3 Study Comparing Once Daily SB204 and Vehicle Gel in Acne
- Conditions
- Acne Vulgaris
- Interventions
- Drug: SB204 4%Drug: Vehicle Gel
- First Posted Date
- 2016-01-29
- Last Posted Date
- 2023-07-24
- Lead Sponsor
- Novan, Inc.
- Target Recruit Count
- 1330
- Registration Number
- NCT02667444
- Locations
- 🇺🇸
CIL #142, Miami, Florida, United States
🇺🇸CIL #111, San Diego, California, United States
🇺🇸CIL #191, Overland Park, Kansas, United States
A Thorough ECG Study in Subjects With Acne Vulgaris Treated With SB204
- Conditions
- Acne Vulgaris
- Interventions
- Drug: SB204 4%Drug: SB204 8% or 12%Drug: Vehicle
- First Posted Date
- 2015-10-20
- Last Posted Date
- 2018-11-19
- Lead Sponsor
- Novan, Inc.
- Target Recruit Count
- 56
- Registration Number
- NCT02581072
- Locations
- 🇺🇸
Spaulding Clinical Research, LLC, West Bend, Wisconsin, United States
Topical NVN1000 for the Treatment of External Genital and Perianal Warts
- Conditions
- Genital WartsPerianal Warts
- Interventions
- Drug: NVN1000 8% GelDrug: NVN1000 16%Drug: VehicleDrug: NVN1000 24%
- First Posted Date
- 2015-06-03
- Last Posted Date
- 2023-04-06
- Lead Sponsor
- Novan, Inc.
- Target Recruit Count
- 108
- Registration Number
- NCT02462187
- Locations
- 🇺🇸
PPD 137, Fountain Valley, California, United States
🇺🇸PPD 134, Atlanta, Georgia, United States
🇺🇸PPD 135, Philadelphia, Pennsylvania, United States
A Phase 1 Study Assessing Local Cutaneous Effects of SB204
- First Posted Date
- 2014-09-26
- Last Posted Date
- 2018-11-19
- Lead Sponsor
- Novan, Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT02250430
- Locations
- 🇺🇸
KGL, Broomall, Pennsylvania, United States
P2 Multi-center Study of SB204 Gel in the Treatment of Acne Vulgaris
- Conditions
- Acne Vulgaris
- Interventions
- Drug: Vehicle GelDrug: SB204 4%Drug: SB204 2%
- First Posted Date
- 2014-09-17
- Last Posted Date
- 2023-05-31
- Lead Sponsor
- Novan, Inc.
- Target Recruit Count
- 213
- Registration Number
- NCT02242760
- Locations
- 🇺🇸
QST Site #103, Boca Raton, Florida, United States
🇺🇸QST Site #111, San Diego, California, United States
🇺🇸QST Site # 121, Minneapolis, Minnesota, United States
A 2 Period Cross-over Pharmacokinetic Study of SB204 in Acne Vulgaris
- First Posted Date
- 2014-06-16
- Last Posted Date
- 2015-04-03
- Lead Sponsor
- Novan, Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT02164084
- Locations
- 🇺🇸
Spaulding Clinical Research, LLC, West Bend, Wisconsin, United States
A Phase 1 Study Evaluating Safety and Tolerability of NVN1000 Gel
- Conditions
- Acne Vulgaris
- Interventions
- Drug: Vehicle GelDrug: NVN1000 4% Gel
- First Posted Date
- 2013-05-01
- Last Posted Date
- 2018-11-19
- Lead Sponsor
- Novan, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT01844739
- Locations
- 🇺🇸
KGL, Broomall, Pennsylvania, United States
A Phase 2, 3 Arm Study of NVN1000 Gel and Vehicle Gel in Subjects With Acne
- Conditions
- Acne Vulgaris
- Interventions
- Drug: NVN1000 1% GelDrug: NVN1000 4% GelDrug: Vehicle Gel
- First Posted Date
- 2013-05-01
- Last Posted Date
- 2018-11-19
- Lead Sponsor
- Novan, Inc.
- Target Recruit Count
- 153
- Registration Number
- NCT01844752
- Locations
- 🇩🇴
Instituto Dermatologico & Cirugia de Piel, Santo Domingo, Dominican Republic
🇭🇳Hospital Y Clinica Bendana, San Pedro Sula, Honduras
🇵🇦Hosptal Punta Pacifica, Panama City, Panama
A Phase 1, 3 Day Study of Safety and Tolerability of NVN1000 Topical Gel in Healthy Volunteers
- Conditions
- Acne Vulgaris
- Interventions
- Drug: Topical Gel VehicleDrug: 8% NVN1000 Topical GelDrug: 8% NVN1000 Topical Gel and moisturizer
- First Posted Date
- 2012-12-24
- Last Posted Date
- 2019-09-10
- Lead Sponsor
- Novan, Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT01755247
- Locations
- 🇺🇸
KGL, Inc, Broomall, Pennsylvania, United States
Cutaneous Tolerability and Safety of NVN1000 Topical Gel in Healthy Volunteers
- Conditions
- Acne Vulgaris
- Interventions
- Drug: 2% NVN1000 Topical GelDrug: 4% NVN1000 Topical GelDrug: Vehicle Topical GelDrug: 8% NVN1000 Topical Gel
- First Posted Date
- 2012-09-27
- Last Posted Date
- 2020-01-30
- Lead Sponsor
- Novan, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT01694810
- Locations
- 🇺🇸
KGL, Inc, Broomall, Pennsylvania, United States